77 related articles for article (PubMed ID: 11721369)
1. [Advances in the study of etiology and differentiation induction mechanism of acute promyelocytic leukemia].
Liu T; Mao M; Chen Z; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 1999 Dec; 20(12):666-8. PubMed ID: 11721369
[No Abstract] [Full Text] [Related]
2. Marked for death.
Petrie K; Zelent A
Nat Cell Biol; 2008 May; 10(5):507-9. PubMed ID: 18454129
[No Abstract] [Full Text] [Related]
3. A new PML-RARs fusion transcript hints at the important role of PML dysregulation in the pathogenesis of APL.
Opalinska J; Zhou L; Verma A
Leuk Lymphoma; 2007 Mar; 48(3):443-4. PubMed ID: 17454578
[No Abstract] [Full Text] [Related]
4. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
[TBL] [Abstract][Full Text] [Related]
5. Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains.
Grignani F; Testa U; Rogaia D; Ferrucci PF; Samoggia P; Pinto A; Aldinucci D; Gelmetti V; Fagioli M; Alcalay M; Seeler J; Grignani F; Nicoletti I; Peschle C; Pelicci PG
EMBO J; 1996 Sep; 15(18):4949-58. PubMed ID: 8890168
[TBL] [Abstract][Full Text] [Related]
6. [Role of retinoic acid in the treatment of acute promyelocytic leukemia].
Gutiérrez de Guzmán J; Kantarjian H
Sangre (Barc); 1993 Oct; 38(5):375-8. PubMed ID: 8140499
[No Abstract] [Full Text] [Related]
7. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha.
Duprez E; Lillehaug JR; Naoe T; Lanotte M
Oncogene; 1996 Jun; 12(11):2451-9. PubMed ID: 8649787
[TBL] [Abstract][Full Text] [Related]
8. [Molecular basis of arsenic action in promyelocytic leukemia cells].
Wysocki R; Wiśniewska E
Postepy Biochem; 2002; 48(2):121-30. PubMed ID: 12362602
[No Abstract] [Full Text] [Related]
9. Molecular pathology of acute promyelocytic leukemia.
Chang KS
Hematol Pathol; 1993; 7(4):209-23. PubMed ID: 8113150
[No Abstract] [Full Text] [Related]
10. [PML (promyelocytic leukemia). Oncogene].
Soussi T; de Thé H
Bull Cancer; 1999 Feb; 86(2):133. PubMed ID: 10094521
[No Abstract] [Full Text] [Related]
11. Medicine. Poisonous contacts.
Kogan SC
Science; 2010 Apr; 328(5975):184-5. PubMed ID: 20378808
[No Abstract] [Full Text] [Related]
12. Delayed or insufficient restoration of PML and PML-RAR alpha subcellular localization after exposure in vitro to retinoic acids in all-trans retinoic acid-resistant APL cells.
Naoe T; Yoshida H; Kitamura K; Chino M; Osumi K; Ohno R
Leukemia; 1995 Sep; 9(9):1610-1. PubMed ID: 7658735
[No Abstract] [Full Text] [Related]
13. [All-trans retinoic acid therapy in acute promyelocytic leukemia--current status and prospect].
Kitamura K; Takeshita A; Ono R; Naoe T
Rinsho Ketsueki; 1996 Sep; 37(9):760-5. PubMed ID: 8914458
[No Abstract] [Full Text] [Related]
14. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway.
Yoshida H; Kitamura K; Tanaka K; Omura S; Miyazaki T; Hachiya T; Ohno R; Naoe T
Cancer Res; 1996 Jul; 56(13):2945-8. PubMed ID: 8674046
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein.
Vallian S; Gäken JA; Gingold EB; Kouzarides T; Chang KS; Farzaneh F
Oncogene; 1998 Jun; 16(22):2843-53. PubMed ID: 9671405
[TBL] [Abstract][Full Text] [Related]
16. Cell biology: an unexpected social servant.
Le Roy C; Wrana JL
Nature; 2004 Sep; 431(7005):142. PubMed ID: 15356616
[No Abstract] [Full Text] [Related]
17. Whole-genome sequencing and acute promyelocytic leukemia.
Lo-Coco F; Sanz MA
JAMA; 2011 Aug; 306(6):610; author reply 610-1. PubMed ID: 21828321
[No Abstract] [Full Text] [Related]
18. Retinoic acid receptor alpha in acute promyelocytic leukaemia.
de Thé H; Dejean A
Cancer Surv; 1992; 14():195-203. PubMed ID: 1330303
[TBL] [Abstract][Full Text] [Related]
19. Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies.
Hodges M; Tissot C; Howe K; Grimwade D; Freemont PS
Am J Hum Genet; 1998 Aug; 63(2):297-304. PubMed ID: 9683622
[No Abstract] [Full Text] [Related]
20. Haploinsufficiency for tumor suppression: the hazards of being single and living a long time.
Largaespada DA
J Exp Med; 2001 Feb; 193(4):F15-8. PubMed ID: 11181707
[No Abstract] [Full Text] [Related]
[Next] [New Search]
